- November 22, 2026
- Updated 7:59 am
Heidi Overton’s FDA Nomination Withdrawn
The White House has retracted Heidi Overton’s nomination to lead the Food and Drug Administration (FDA). This decision came just before her confirmation vote, due to insufficient backing from Senate lawmakers. A senior administration official informed Axios about the lack of support on Capitol Hill. The White House also confirmed the withdrawal to The Post.
Overton faced opposition from both parties in Congress. Her ties to big tobacco, backing of vaping, and anti-abortion views have been points of contention. Anti-Overton signs have appeared on Capitol Hill, indicating organized opposition to her nomination.
A notable sign featured a crossed-out photo of Overton with a vape, reading ‘Say no to Heidi Vaperton.’ The image of Health and Human Services Secretary Robert F. Kennedy Jr. with Overton in the Oval Office on August 10, 2026, suggests ongoing discussions about her role.
This situation is still unfolding. More updates are anticipated.